OBJECTIVES: Telomeres are structures at chromosome ends that contribute to maintaining genomic integrity. Telomere shortening with repeated cell divisions may lead to genomic instability and carcinogenesis. Studies suggest that shorter telomeres in constitutional DNA are associated with bladder, breast, lung, and renal cancer. Ovarian cancer tissues also have shortened telomeres and increased telomerase activity, suggesting that telomere abnormalities may be related to ovarian cancer. METHODS: We investigated leukocyte telomere length in 99 women with serous ovarian adenocarcinoma and 100 age-matched cancer-free controls enrolled in a population-based case-control study. RESULTS: Cases tended to have shorter telomeres than controls (P (wilcoxon) = 0.002). Compared to subjects with telomere lengths in the longest tertile, those in the middle and shortest tertiles showed respective age-adjusted odds ratios (95% confidence intervals) of 2.69 (1.23-5.88) and 3.39 (1.54-7.46) (P (trend) = 0.002). Strongest associations were found for subjects with poorly differentiated carcinomas (OR = 4.89, 95% CI 1.93-12.34). CONCLUSIONS: This study shows that short leukocyte telomeres are associated with serous ovarian adenocarcinoma. These findings should be confirmed in large, prospective studies.
OBJECTIVES: Telomeres are structures at chromosome ends that contribute to maintaining genomic integrity. Telomere shortening with repeated cell divisions may lead to genomic instability and carcinogenesis. Studies suggest that shorter telomeres in constitutional DNA are associated with bladder, breast, lung, and renal cancer. Ovarian cancer tissues also have shortened telomeres and increased telomerase activity, suggesting that telomere abnormalities may be related to ovarian cancer. METHODS: We investigated leukocyte telomere length in 99 women with serous ovarian adenocarcinoma and 100 age-matched cancer-free controls enrolled in a population-based case-control study. RESULTS: Cases tended to have shorter telomeres than controls (P (wilcoxon) = 0.002). Compared to subjects with telomere lengths in the longest tertile, those in the middle and shortest tertiles showed respective age-adjusted odds ratios (95% confidence intervals) of 2.69 (1.23-5.88) and 3.39 (1.54-7.46) (P (trend) = 0.002). Strongest associations were found for subjects with poorly differentiated carcinomas (OR = 4.89, 95% CI 1.93-12.34). CONCLUSIONS: This study shows that short leukocyte telomeres are associated with serous ovarian adenocarcinoma. These findings should be confirmed in large, prospective studies.
Authors: M Kammori; K Takubo; K Nakamura; E Furugouri; H Endo; H Kanauchi; Y Mimura; M Kaminishi Journal: Cancer Lett Date: 2000-10-31 Impact factor: 8.679
Authors: Xifeng Wu; Christopher I Amos; Yong Zhu; Hua Zhao; Barton H Grossman; Jerry W Shay; Sherry Luo; Waun Ki Hong; Margaret R Spitz Journal: J Natl Cancer Inst Date: 2003-08-20 Impact factor: 13.506
Authors: Dana E Rollison; P K Epling-Burnette; Jong Y Park; Ji-Hyun Lee; Hyun Park; Kristen Jonathan; Ashley L Cole; Jeffrey S Painter; Mayenha Guerrier; Johana Meléndez-Santiago; William Fulp; Rami Komrokji; Jeffrey Lancet; Alan F List Journal: Leuk Lymphoma Date: 2011-06-03
Authors: Kathryn L Terry; Shelley S Tworoger; Allison F Vitonis; Jason Wong; Linda Titus-Ernstoff; Immaculata De Vivo; Daniel W Cramer Journal: Cancer Epidemiol Biomarkers Prev Date: 2012-01-20 Impact factor: 4.254
Authors: Joanne Kotsopoulos; Jennifer Prescott; Immaculata De Vivo; Isabel Fan; John Mclaughlin; Barry Rosen; Harvey Risch; Ping Sun; Steven A Narod Journal: Cancer Epidemiol Biomarkers Prev Date: 2014-08-26 Impact factor: 4.254
Authors: Julie M Cunningham; Ruth A Johnson; Kristin Litzelman; Halcyon G Skinner; Songwon Seo; Corinne D Engelman; Russell J Vanderboom; Grace W Kimmel; Ronald E Gangnon; Douglas L Riegert-Johnson; John A Baron; John D Potter; Robert Haile; Daniel D Buchanan; Mark A Jenkins; David N Rider; Stephen N Thibodeau; Gloria M Petersen; Lisa A Boardman Journal: Cancer Epidemiol Biomarkers Prev Date: 2013-09-09 Impact factor: 4.254
Authors: Andrew J Pellatt; Roger K Wolff; Gabriela Torres-Mejia; Esther M John; Jennifer S Herrick; Abbie Lundgreen; Kathy B Baumgartner; Anna R Giuliano; Lisa M Hines; Laura Fejerman; Richard Cawthon; Martha L Slattery Journal: Genes Chromosomes Cancer Date: 2013-04-30 Impact factor: 5.006
Authors: Halcyon G Skinner; Ronald E Gangnon; Kristin Litzelman; Ruth A Johnson; Suresh T Chari; Gloria M Petersen; Lisa A Boardman Journal: Cancer Epidemiol Biomarkers Prev Date: 2012-10-23 Impact factor: 4.254